Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy.

Bakermans-Kranenburg MJ, van I Jzendoorn MH.

Transl Psychiatry. 2013 May 21;3:e258. doi: 10.1038/tp.2013.34. Review.

2.

Effect of intranasal oxytocin administration on psychiatric symptoms: A meta-analysis of placebo-controlled studies.

Hofmann SG, Fang A, Brager DN.

Psychiatry Res. 2015 Aug 30;228(3):708-14. doi: 10.1016/j.psychres.2015.05.039.

3.

Intranasal Oxytocin Administration Dampens Amygdala Reactivity towards Emotional Faces in Male and Female PTSD Patients.

Koch SB, van Zuiden M, Nawijn L, Frijling JL, Veltman DJ, Olff M.

Neuropsychopharmacology. 2016 May;41(6):1495-504. doi: 10.1038/npp.2015.299.

PMID:
26404844
4.

Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders.

Tachibana M, Kagitani-Shimono K, Mohri I, Yamamoto T, Sanefuji W, Nakamura A, Oishi M, Kimura T, Onaka T, Ozono K, Taniike M.

J Child Adolesc Psychopharmacol. 2013 Mar;23(2):123-7. doi: 10.1089/cap.2012.0048.

PMID:
23480321
5.

Potential for oxytocin use in children and adolescents with mental illness.

Netherton E, Schatte D.

Hum Psychopharmacol. 2011 Jun-Jul;26(4-5):271-81. doi: 10.1002/hup.1212. Review.

PMID:
21751251
6.

The role of oxytocin in social bonding, stress regulation and mental health: an update on the moderating effects of context and interindividual differences.

Olff M, Frijling JL, Kubzansky LD, Bradley B, Ellenbogen MA, Cardoso C, Bartz JA, Yee JR, van Zuiden M.

Psychoneuroendocrinology. 2013 Sep;38(9):1883-94. doi: 10.1016/j.psyneuen.2013.06.019. Review.

7.

Relative effects of CBT and pharmacotherapy in depression versus anxiety: is medication somewhat better for depression, and CBT somewhat better for anxiety?

Roshanaei-Moghaddam B, Pauly MC, Atkins DC, Baldwin SA, Stein MB, Roy-Byrne P.

Depress Anxiety. 2011 Jul;28(7):560-7. doi: 10.1002/da.20829.

PMID:
21608087
8.

[Oxytocin: the hormone of love, trust and social bond. Clinical use in autism and social phobia].

Martin-Du Pan RC.

Rev Med Suisse. 2012 Mar 21;8(333):627-30. French.

PMID:
22506444
9.

Prediction of drug effect by diagnostic decision tree.

Klein DF, Honigfeld G, Feldman S.

Dis Nerv Syst. 1968 May;29(5):Suppl:159-87. No abstract available.

PMID:
4876986
10.

A systematic review of off-label uses of memantine for psychiatric disorders.

Zdanys K, Tampi RR.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1362-74. doi: 10.1016/j.pnpbp.2008.01.008. Review.

PMID:
18262702
11.

Pharmacotherapy of anxious disorders.

Bourin M, Lambert O.

Hum Psychopharmacol. 2002 Dec;17(8):383-400. Review.

PMID:
12457374
12.

Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response.

Acheson DT, Feifel D, Kamenski M, Mckinney R, Risbrough VB.

Depress Anxiety. 2015 Jun;32(6):400-7. doi: 10.1002/da.22362.

PMID:
25826649
13.

Oxytocin: a therapeutic target for mental disorders.

Matsuzaki M, Matsushita H, Tomizawa K, Matsui H.

J Physiol Sci. 2012 Nov;62(6):441-4. doi: 10.1007/s12576-012-0232-9. Review.

PMID:
23007624
14.

Prosocial effects of oxytocin and clinical evidence for its therapeutic potential.

Striepens N, Kendrick KM, Maier W, Hurlemann R.

Front Neuroendocrinol. 2011 Oct;32(4):426-50. doi: 10.1016/j.yfrne.2011.07.001. Review.

PMID:
21802441
15.

Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder.

Domes G, Heinrichs M, Kumbier E, Grossmann A, Hauenstein K, Herpertz SC.

Biol Psychiatry. 2013 Aug 1;74(3):164-71. doi: 10.1016/j.biopsych.2013.02.007.

PMID:
23510581
16.

Oxytocin and autism: a systematic review of randomized controlled trials.

Preti A, Melis M, Siddi S, Vellante M, Doneddu G, Fadda R.

J Child Adolesc Psychopharmacol. 2014 Mar;24(2):54-68. doi: 10.1089/cap.2013.0040. Review.

PMID:
24679173
17.

Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome.

Hall SS, Lightbody AA, McCarthy BE, Parker KJ, Reiss AL.

Psychoneuroendocrinology. 2012 Apr;37(4):509-18. doi: 10.1016/j.psyneuen.2011.07.020.

18.

The pharmacological management of childhood anxiety disorders: a review.

Reinblatt SP, Riddle MA.

Psychopharmacology (Berl). 2007 Mar;191(1):67-86. Review.

PMID:
17205317
19.

[Therapeutic effects of oxytocin in autism: Current status of the research].

Gauthier C, Doyen C, Amado I, Lôo H, Gaillard R.

Encephale. 2016 Feb;42(1):24-31. doi: 10.1016/j.encep.2015.07.006. Review. French.

PMID:
26797566
20.

[Double-blind trial treatment of anxiety with b 5833].

Cloquette R.

Acta Psychiatr Belg. 1974 May;74(3):317-26. French. No abstract available.

PMID:
4156149
Items per page

Supplemental Content

Support Center